The percentage of breast and ovarian cancer cases carrying BRCA1/2 germline truncation variants in the TCGA cohort was 4.4% and 11.6%, respectively, consistent with previous reports39, 40, 41, 42. Here, BRCA1 is linked to ovarian carcinoma.